How to treat anaplasmosis with doxycycline (Doxycycline)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Anaplasmosis

Doxycycline 100 mg twice daily for 10 days is the recommended first-line treatment for anaplasmosis in all patients, regardless of age, including children and pregnant women, due to the risk of complications and potential fatality if left untreated. 1

Treatment Regimen

  • Adults: Doxycycline 100 mg twice daily orally (or intravenously for patients unable to take oral medications) for 10 days 1
  • Children: Doxycycline 4 mg/kg per day in 2 divided doses (maximum 100 mg per dose) orally or intravenously for 10 days 1

Rationale for Doxycycline Use

Doxycycline is the treatment of choice for anaplasmosis because:

  1. It is highly effective against Anaplasma phagocytophilum
  2. The mortality rate is less than 1% with appropriate treatment 2
  3. Alternative antibiotics have shown limited efficacy or treatment failure

Special Populations

Children

  • Despite traditional concerns about tooth discoloration, doxycycline should be used in children of all ages with anaplasmosis due to the potentially life-threatening nature of the infection 1
  • The risk of dental staining with short courses of doxycycline is minimal compared to the risk of untreated anaplasmosis 3

Pregnant Women

  • Doxycycline should be used even during pregnancy due to the potentially severe complications of untreated anaplasmosis 1
  • There is documented successful treatment of a pregnant woman who developed symptomatic anaplasmosis during childbirth 1

Alternative Treatment

For patients with documented severe allergy to tetracyclines:

  • Rifampin 300 mg twice daily orally for adults and 10 mg/kg twice daily for children (maximum 300 mg per dose) for 7-10 days 1
  • Important caveat: Patients treated with rifampin should be closely monitored to ensure resolution of clinical and laboratory abnormalities 1

Treatment Failures and Pitfalls

  • Avoid fluoroquinolones: Despite in vitro activity against A. phagocytophilum, levofloxacin has been associated with clinical and microbiological relapse after treatment completion 4
  • Do not delay treatment: Empiric therapy should be started based on clinical suspicion without waiting for laboratory confirmation 2
  • Monitor for response: Clinical improvement typically occurs within 24-48 hours; lack of improvement should prompt reevaluation of diagnosis
  • Complete the full course: Even if symptoms resolve quickly, the full 10-day course is necessary to prevent relapse

Diagnostic Confirmation

While treatment should not be delayed pending results, diagnostic confirmation can be obtained through:

  • PCR testing (preferred method during acute illness) 2
  • Serology (IgG titers ≥1:64 indicate recent or current infection)
  • Examination of peripheral blood smears for characteristic morulae in neutrophils

Follow-up

  • Clinical improvement is typically seen within 24-48 hours of starting doxycycline
  • Follow-up testing is not routinely required if symptoms resolve
  • Monitor for resolution of laboratory abnormalities (thrombocytopenia, leukopenia, elevated liver enzymes)

Prophylaxis Considerations

Prophylactic doxycycline after tick bites is not routinely recommended for anaplasmosis alone, as evidence for its efficacy is limited 5. The focus should be on prompt recognition and treatment of symptoms if they develop.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Human Granulocytic Anaplasmosis.

Infectious disease clinics of North America, 2022

Guideline

Lyme Disease Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis.

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2006

Research

A Traumatic Tick Bite: A Case Report.

Clinical practice and cases in emergency medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.